Page 19 of 23
The Journal of Organic Chemistry
6H), 1.40-1.51 (m, 1H), 1.53-164 (m, 2H), 3.58-3.73 (m, 2H). 13C oil; 132 mg, 59%; E/Z > 98:2; dr = 95:05; H NMR (400 MHz,
NMR (100 MHz, CDCl3) δ 10.4, 10.7, 10.7, 12.4, 12.6, 14.7, 14.8, CDCl3) δ 0.34 (d, J = 4.4 Hz, 1H), 0.55 (d, J = 4.4 Hz, 1H), 0.85
16.0, 19.6, 24.4 & 24.4, 26.6, 26.7, 27.3, 27.6, 36.3, 36.4, 36.8, (t, J = 7.0 Hz, 3H), 1.03 (s, 3H), 1.10 (s, 6H), 1.12-1.23 (m, 7H),
63.2. HRMS (ESI-TOF) m/z: calcd for C12H23O+ [M + H]+ 1.28-1.38 (m, 1H), 1.40-1.50 (m, 1H), 1.72 (s, 1H), 1.89 (td, J =
1
1
2
3
4
5
6
7
8
183.1749, found 183.1738.
9.6, 2.8 Hz, 1H), 5.09 (dd, J = 15.6, 9.6 Hz, 1H), 5.47 (d, J =
15.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 14.3, 19.2 (d, J =
19.1 Hz), 21.6, 22.1, 22.4, 23.3, 26.0, 26.7, 27.9, 28.1, 32.2, 55.2,
72.1, 128.4, 140.7. HRMS (ESI-TOF) m/z: calcd for C15H28DO+
[M + H]+ 226.2281, found 226.2288.
(3S*,4R*)-1,1-dimethyl-4-(pent-4-en-1-
yl)spiro[2.2]pentane (3a). Colorless oil; 660 mg, 62%; dr =
95:5 (relative configuration of the major isomer determined
by NOESY experiments); H NMR (400 MHz, CDCl3) δ 0.26
1
9
(dd, J = 4.4, 3.9 Hz, 1H), 0.42 (d, J = 4.4 Hz, 1H), 0.53 (d, J = (R*)-3-((E)-2-((S*)-1-(but-3-en-1-yl)-2,2-
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4.0 Hz, 1H), 0.78 (dd, J = 8.3, 3.8 Hz, 1H), 0.86-0.96 (m, 1H), dimethylcyclopropyl)vinyl)-2-methylhexan-2-ol
(4b).
1
0.95-1.14 (m, 6H), 1.20-1.34 (m, 2H), 1.36-1.49 (m, 2H), 2.04 Colorless oil; 174 mg, 66%; E/Z > 98:2; dr = 90:10; H NMR
(m, 2H), 4.82-5.07 (m, 2H), 5.70-5.88 (m, 1H). 13C NMR (100 (400 MHz, CDCl3) δ 0.26 (d, J = 4.5 Hz, 1H), 0.54 (d, J = 4.5
MHz, CDCl3) δ 10.9, 15.7, 15.9, 17.6, 23.3, 23.5, 27.3, 28.8, 32.6, Hz, 1H), 0.85 (t, J = 7.1 Hz, 3H), 0.99 (s, 3H), 1.02-1.53 (m,
+
33.8, 114.2, 139.2. HRMS (ESI-TOF) m/z: calcd for C12H21 [M 14H), 1.58-1.70 (m, 2H), 1.95 (ddd, J = 10.6, 9.2, 2.5 Hz, 1H),
+ H]+ 165.1643, found 165.1663.
2.00-2.16 (m, 2H), 4.83-5.01 (m, 2H), 5.11 (dd, J = 15.4, 9.7 Hz,
1H), 5.51 (d, J = 15.5 Hz, 1H), 5.80 (ddt, J = 17.1, 10.2, 6.8 Hz,
1H). 13C NMR (100 MHz, CDCl3) δ 14.2, 21.5, 21.9, 22.1, 23.5,
25.2, 27.2, 31.4, 32.1, 32.3, 33.8, 55.1, 114.2, 131.2, 137.5, 139.4.
HRMS (ESI-TOF) m/z: calcd for C18H33O+ [M + H]+ 265.2531,
found 265.2543.
(3S*,4R*)-4-(hex-5-en-1-yl)-1,1-
dimethylspiro[2.2]pentane (3b). Colorless oil; 252 mg,
1
78%; dr = 95:5; H NMR (400 MHz, CDCl3) δ 0.25 (t, J = 4.1
Hz, 1H), 0.42 (d, J = 3.9 Hz, 1H), 0.53 (d, J = 3.9 Hz, 1H), 0.77
(dd, J = 7.7, 4.3 Hz, 1H), 0.86-0.95 (m, 1H), 0.95-1.15 (m, 6H),
1.17-1.48 (m, 6H), 1.97-2.09 (m, 2H), 4.86-5.02 (m, 2H), 5.70- (R*)-3-ethyl-4-((E)-2-((S*)-1,2,2-
5.89 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 11.06, 15.9, 16.2, trimethylcyclopropyl)vinyl)heptan-3-ol (4c). Colorless
17.8, 23.5, 23.7, 27.5, 29.1, 33.1, 34.0, 114.34, 139.4. HRMS (ESI- oil; 191 mg, 76%; E/Z > 98:2; dr = 90:10; (both diastereomers
+
1
TOF) m/z: calcd for C13H23 [M + H]+ 179.1800, found: are described as a mixture): H NMR (400 MHz, CDCl3) δ
179.1827.
0.33 (t, J = 4.4 Hz, 1H), 0.54 (d, J = 4.4 Hz, 1H), 0.79-0.89 (m,
9H), 0.96-1.69 (m, 18H), 2.06 (ddd, J = 11.8, 9.6, 2.0 Hz, 1H),
5.16 (dd, J = 15.5, 9.7 Hz, 1H), 5.43 (d, J = 15.5 Hz, 1H). 13C
NMR (100 MHz, CDCl3) δ 7.7, 7.8, 14.3, 19.6, 21.4, 21.5, 22.1,
22.4, 23.3, 26.1, 28.1 & 28.2, 28.5, 28.6, 28.9, 29.1, 31.1 & 31.2,
50.3, 50.4, 75.4, 75.6, 128.4, 139.8. HRMS (ESI-TOF) m/z:
calcd for C17H33O+ [M + H]+ 253.2531, found 253.2542.
(3S*,4R*)-4-(hept-6-en-1-yl)-1,1-
dimethylspiro[2.2]pentane (3c). Colorless oil; 261 mg, 81%;
dr =95:5; 1H NMR (400 MHz, CDCl3) δ 0.25 (t, J = 4.1 Hz, 1H),
0.39-0.47 (m, 1H), 0.53 (d, J = 3.9 Hz, 1H), 0.61-0.80 (m, 1H),
0.86-0.95 (m, 1H), 0.95-1.13 (m, 6H), 1.17-1.44 (m, 8H), 1.97-
2.08 (m, 2H), 4.86-5.03 (m, 2H), 5.72-5.86 (m, 1H). 13C NMR
(100 MHz, CDCl3) δ 11.0, 15.9, 16.3, 17.8, 23.5, 23.7, 27.5, 29.2, (R*)-4-((E)-2-((S*)-2,2-dimethyl-1-(methyl-
29.4, 29.5, 33.2, 34.0, 114.3, 139.4. HRMS (ESI-TOF) m/z: d)cyclopropyl)vinyl)-3-ethylheptan-3-ol (4cd). Colorless
calcd for C14H25+ [M + H]+ 193.1956, found: 193.1973.
oil; 200 mg, 79%; E/Z > 98:2; dr = 85:15; (both diastereomers
are described as a mixture): H NMR (400 MHz, CDCl3) δ
1
(3S*,4R*)-4-allyl-1-isobutyl-1-methylspiro[2.2]pentane
(3d). Colorless oil; 1.309 g, 62%; dr = 65:30:5:0 (relative con-
figuration of the major isomer determined by NOESY experi-
0.32 (d, J = 4.3 Hz, 1H), 0.54 (d, J = 4.3 Hz, 1H), 0.75-0.93 (m,
9H), 1.03 (s, 3H), 1.09 (s, 3H), 1.12-1.25 (m, 3H), 1.26-1.65 (s,
8H), 2.06 (ddd, J = 11.1, 9.6, 2.4 Hz, 1H), 5.15 (dd, J = 15.5, 9.6
Hz, 1H), 5.41 (minor) & 5.43 (major) (d, J = 15.5 Hz, 1H). 13C
NMR (100 MHz, CDCl3) δ 7.7, 7.8, 14.3, 14.3, 19.3 (t, J = 19.1
Hz), 21.4, 21.5, 22.0, 22.4, 23.3, 23.4, 26.0, 28.1, 28.2, 28.5, 28.6,
28.9, 29.1, 31.2, 31.2, 50.3, 50.4, 75.4, 75.6, 128.1, 128.4, 139.9.
HRMS (ESI-TOF) m/z: calcd for C17H30OD [M – OH]+
236.2483, found 236.2490.
1
ments); : H NMR (400 MHz, CDCl3) δ 0.32-0.38 (m, 1H),
0.47-0.51 (m, 1H), 0.60-0.64 (m, 1H), 1.13-1.45 (m, 2H), 1.45-
1.84 (m, 12H), 2.04 (t, J = 6.5 Hz, 2H), 4.95 (d, J = 10.1 Hz, 1H),
5.06 (d, J = 17.1 Hz, 1H), 5.86 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H).
13C NMR (100 MHz, CDCl3) δ 10.4, 11.5, 15.0, 16.0, 17.8, 17.9,
18.6, 18.7, 20.8, 21.0, 22.8, 23.4, 26.4, 26.4, 26.9, 27.0, 37.5,
46.6, 46.8, 114.5, 138.4. HRMS (ESI-TOF) m/z: calcd for
C13H23O [M + H2O]+ 195.1749, found 195.1758.
(R*)-2-methyl-3-((E)-2-((S*)-1,2,2-
trimethylcyclopropyl)vinyl)heptan-2-ol (4d). Colorless
(R*)-2-methyl-3-((E)-2-((S*)-1,2,2-
trimethylcyclopropyl)vinyl)hexan-2-ol (4a). Colorless oil;
143 mg, 64%; E/Z > 99:1; dr = 95:05; H NMR (400 MHz,
oil; 147 mg, 62%; E/Z > 98:2; dr = 80:20; (both diastereomers
1
1
are described as a mixture): H NMR (400 MHz, CDCl3) δ
0.33 (t, J = 4.4 Hz, 1H), 0.54 (d, J = 4.3 Hz, 1H), 0.84 (t, J = 6.8
Hz, 3H), 1.02 (s, 3H), 1.04-1.18 (m, 13H), 1.18-1.36 (m, 4H),
1.45-1.56 (m, 1H), 1.74 (s, 1H), 1.88 (ddd, J = 10.9, 9.6, 2.5 Hz,
1H), 5.10 (dd, J = 15.4, 9.7 Hz, 1H), 5.46 (m, 1H). 13C NMR (100
MHz, CDCl3) δ 14.3, 19.6, 22.1, 22.4, 22.8, 22.8, 23.3, 23.4, 26.0
& 26.1, 26.8 & 26.9, 27.2, 28.1, 28.4, 29.5, 29.6, 30.5, 30.7, 55.4,
72.1, 72.4, 128.2, 128.4, 140.7. HRMS (ESI-TOF) m/z: calcd for
C16H31O+ [M + H]+ 239.2375, found: 239.2382.
CDCl3) δ 0.33 (d, J = 4.4 Hz, 1H), 0.55 (d, J = 4.4 Hz, 1H), 0.85
(t, J = 7.2 Hz, 3H), 1.03 (s, 3H), 1.07-1.25 (m, 14H), 1.26-1.51 (m,
2H), 1.73 (s, 1H), 1.92 (ddd, J = 11.1, 9.7, 2.5 Hz, 1H), 5.11 (dd, J
= 15.5, 9.7 Hz, 1H), 5.47 (d, J = 15.5 Hz, 1H). 13C NMR (100
MHz, CDCl3) δ 14.3, 19.5, 21.6, 22.1, 22.4, 23.3, 26.1, 26.8, 27.3,
28.1, 32.2, 55.2, 72.1, 128.4, 140.7. HRMS (ESI-TOF) m/z: calcd
for C15H29O+ [M + H]+ 225.2218, found 225.2225.
(R*)-3-((E)-2-((S*)-2,2-dimethyl-1-(methyl-
d)cyclopropyl)vinyl)-2-methylhexan-2-ol (4ad). Colorless
19
ACS Paragon Plus Environment